SHANGHAI, March 12, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2019. Fourth Quarter 2019 Highlights

SEATTLE and VANCOUVER, British Columbia, March 12, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced that additional analyses from the ORCA-1 Phase 2b t

STOCKHOLM, March 12, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, introduces Coronary Intermediate as the latest software addition to the Coronary Product Portfolio. Coronary Intermediate follows the introduction of Coronary Essentials three months earlier at the 20th International Meeting on Simulation i

CAMBRIDGE, Mass., March 12, 2020 /PRNewswire/ -- Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to invent breakthrough protein degrader medicines for patients, today announced the closing of a $102 million Series C financing. The round was led by Biotechnology Value Fund (BVF) and Redmile Group

LOS ANGELES, March 12, 2020 /PRNewswire/ -- Pulling no punches, the UCLA Anderson Forecasts for the national, state and global economies take a hard look at the potential impacts of COVID-19.

LINKÖPING, Sweden, March 12, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a contract with the Swedish healthcar

STOCKHOLM, March 12, 2020 /PRNewswire/ -- Bactiguard launches HYDROCYN aqua®, a water-based product that has been proven to have a powerful effect on killing previous variants of coronavirus within 15-30 seconds. Previous experience shows that the proven effect can be transferred to new variants of coronavirus and tests on COVID-19 (SARS-CoV-2) are now underway at

GOTHENBURG, Sweden, March 12, 2020 /PRNewswire/ -- Transmission speed of the Covid-19 (corona) virus remains difficult to assess, and Castellum is closely following developments. With a view to shielding the health of shareholders, Board members and co-workers, several new decisions have been made regarding the company's Annual General Meeting, scheduled for

NANJING, China, March 12, 2020 /PRNewswire/ -- Suning International announced that it will donate the first 300 thousand medical masks and other healthcare products, such as protective garment and disinfection products, to support Italy t

TEL AVIV, Israel, March 12, 2020 /PRNewswire/ -- Everads Therapy, an early-stage life sciences company developing the next generation of retinal treatment delivery technologies, today announced that it has signed an option agreement with a large global pharmaceutical company. This is Everads' first commercial agreement, and its signing supports the potential of its